A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of Edoxaban
NCT07113054 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2025-09-16
Summary
The aim of the study is to evaluate the effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of edoxaban in healthy adults
Conditions
- Healthy
Interventions
- DRUG
-
Edoxaban 60 MG [Lixiana]
Single administration of edoxaban
- OTHER
-
Edoxaban 60 MG [Lixiana] + Grapefruit Juice
Coadministration of edoxaban and grapefruit juice
Sponsors & Collaborators
-
Hyewon Chung
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-02
- Primary Completion
- 2025-09-24
- Completion
- 2025-10-31
Countries
- South Korea
Study Locations
More Related Trials
-
The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients
NCT01743300 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their Effects
NCT01409603 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics Study of XG005 Capsule
NCT04499209 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)
NCT00959439 ·Status: COMPLETED ·Phase: PHASE1
-
Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
NCT00137033 ·Status: COMPLETED ·Phase: PHASE4
-
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
NCT00674856 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
NCT00807846 ·Status: COMPLETED ·Phase: PHASE4
-
Celecoxib (Celebrex) in the Management of Acute Renal Colic
NCT00304317 ·Status: WITHDRAWN ·Phase: PHASE4
-
Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study
NCT03167541 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure
NCT00624559 ·Status: COMPLETED ·Phase: PHASE4
-
A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice
NCT00984009 ·Status: COMPLETED ·Phase: PHASE1
-
Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
NCT02413203 ·Status: COMPLETED ·Phase: NA
-
Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E
NCT00761501 ·Status: COMPLETED ·Phase: PHASE1
-
Resveratrol Trial for Relief of Pain in Pseudoachondroplasia
NCT03866200 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers
NCT04639804 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects
NCT00621881 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal
NCT02146391 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain
NCT00170898 ·Status: COMPLETED ·Phase: PHASE4
-
Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian
NCT05181124 ·Status: COMPLETED ·Phase: PHASE1
-
PF-06372865 In Subjects With Chronic Low Back Pain
NCT02262754 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study PK Study With OXP005 and Naprosyn
NCT02351024 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Losartan on Cephalexin
NCT07300670 ·Status: RECRUITING ·Phase: PHASE1
-
Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
NCT00692055 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol
NCT03882762 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare Safety and Effectiveness for Relieving Tenderness of 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel in the Treatment of Strains and Bruises of the Legs.
NCT05026320 ·Status: COMPLETED ·Phase: PHASE2